Early growth response 2 (Egr2) plays opposing roles in committing C3H10T1/2 stem cells to adipocytes and smooth muscle-like cells.
Early growth response 2 (Egr2) plays opposing roles in committing C3H10T1/2 stem cells to adipocytes and smooth muscle-like cells.
复制标题
DOI:
10.1016/j.biocel.2013.06.003
复制
发表时间:
2013-08
期刊:
影响因子:
--
通讯作者:
Shan‐Shan Wang;Haiyan Huang;Su-Zhen Chen;Xi Li;Yang Liu;Wenting Zhang;Q. Tang
中科院分区:
文献类型:
--
作者:
Shan‐Shan Wang;Haiyan Huang;Su-Zhen Chen;Xi Li;Yang Liu;Wenting Zhang;Q. Tang
Early growth response 2 (Egr2) is a zinc-finger transcription factor that acts as an important modulator of a variety of physiological processes, such as cell differentiation, proliferation and apoptosis. Here we showed that Egr2 was downregulated by bone morphogenetic protein (BMP) signaling pathways during the commitment of C3H10T1/2 stem cells to adipocyte lineage. Overexpression of Egr2 completely prevented BMP4-induced adipocyte lineage commitment of C3H10T1/2 stem cells, while simultaneously stimulating early smooth muscle-like differentiation. We also demonstrated that Egr2-induced early smooth muscle-like differentiation is transforming growth factor β1-independent. Egr2 can activate the transcription of early smooth muscle cell specific genes smooth muscle protein 22α and calponin 1. Together, the results indicated a novel role for Egr2 in repressing adipocyte lineage commitment and promoting early smooth muscle-like cell differentiation.